01:51:52 EDT Mon 27 May 2024
Enter Symbol
or Name

Login ID:

C:HUGE - FSD Pharma Inc. Subordinate Voting Shares - http://www.fsdpharma.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
HUGE - C  2.40.47·0.501.00.475-0.025-5.035.615600.50  0.52  0.472.23  0.37515:59:5917:2215 min RT 2¢
CSE - C2.40.47·0.501.00.475-0.025-5.029.413430.50  0.51  0.472.23  0.37515:59:5915 min
NEO ATS - U 0.485-0.015-3.03.5170.50  0.52  0.48515:20:5615 min
CX2 - H 0.500.0011    May 2315 min
CXD - D 0.502.3160.52  0.52  0.5014:30:0815 min
TriAct - M 0.500.303    Sep 11-2015 min

Recent Trades - Last 10 of 60
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:59C0.475-0.02550079 CIBC79 CIBCK
15:49:48C0.495-0.00550079 CIBC79 CIBCK
15:35:09C0.48-0.0250079 CIBC1 AnonymousK
15:24:46C0.47-0.0350079 CIBC79 CIBCK
15:24:46C0.47-0.0350079 CIBC79 CIBCK
15:24:46C0.47-0.0350079 CIBC79 CIBCK
15:24:46C0.47-0.0350079 CIBC79 CIBCK
15:24:46C0.47-0.035007 TD Sec79 CIBCK
15:24:43C0.475-0.02550079 CIBC79 CIBCK
15:24:43C0.475-0.02550079 CIBC79 CIBCK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-05-24 17:22C:HUGE0.475News ReleaseFSD to pay IR Agency $335,669 for one month of services
2024-05-16 15:13C:HUGE0.45News ReleaseFSD talks design of Celly's unbuzzd packaging, logo
2024-05-14 20:12C:HUGE0.485SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-05-14 20:06C:HUGE0.485SEDAR Interim MD & ASEDAR Interim MD & A
2024-05-07 12:47C:HUGENews ReleaseFSD submits Lucid-MS application for ethics review
2024-04-30 14:04C:HUGE0.57News ReleaseFSD Pharma signs agreement with ASPI to conduct trial
2024-04-25 11:46C:HUGE0.63News ReleaseFSD Pharma talks Celly's partnership with Six+One
2024-04-22 12:08C:HUGE0.63News ReleaseFSD Pharma talks Celly unbuzzd rollout
2024-04-17 13:15C:HUGE0.69News ReleaseFSD Pharma expands pipeline to metabolic disorders
2024-04-15 13:41C:HUGE0.82News ReleaseFSD Pharma defers term loan interest payment for Celly
2024-04-08 02:11C:HUGE0.85News ReleaseFSD Pharma has until Oct. 2 to regain Nasdaq compliance
2024-04-01 21:41C:HUGE0.94SEDAR Annual ReportSEDAR Annual Report
2024-03-28 17:29C:HUGE0.96SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-28 17:03C:HUGE0.96SEDAR MD & ASEDAR MD & A
2024-03-27 12:17C:HUGE0.96News ReleaseFSD Pharma to conduct clinical study with iNGENu
2024-03-11 11:17C:HUGE1.06News ReleaseFSD applies for unbuzzd phase 1b trial approval
2024-02-28 12:56C:HUGE1.28News ReleaseFSD Pharma to settle $637,650 debt with shares
2024-02-26 13:29C:HUGE1.28News ReleaseFSD to conduct unbuzzd clinical trial with Ingenu
2024-02-16 20:02C:HUGE1.12News ReleaseFSD Pharma arranges $11.15M (U.S.) ATM offering
2024-02-06 09:01C:HUGE1.10News ReleaseFSD Pharma ex-CEO Bokhari has appeal request denied